Carisma Therapeutics Inc. (CARM) — Strategic Asset Allocation Index
Carisma Therapeutics Inc. (CARM) has a Strategic Asset Allocation Index of 15.9% as of June 2023. Strategic assets (PP&E of $10.64 Million plus long-term investments of $-) total $10.64 Million, measured against net assets of $66.70 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Carisma Therapeutics Inc. Strategic Asset Allocation Index (2021–2021)
This chart shows how Carisma Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2023, the index stands at 15.9%, representing strategic assets of $10.64 Million against net assets of $66.70 Million USD. Explore Carisma Therapeutics Inc. cash conversion from operations to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Carisma Therapeutics Inc. (2021–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Carisma Therapeutics Inc. from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see CARM stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 3.3% | $5.66 Million | $5.66 Million | $- | $171.71 Million | — |